Syros Pharmaceuticals Inc...

NASDAQ: SYRS · Real-Time Price · USD
0.03
0.00 (19.52%)
At close: Jun 09, 2025, 3:26 PM

Syros Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.34 -0.92 -2.25
PEG Ratio
-0.03 0.01 0.10
PS Ratio
22.21 3.05 8.68
PB Ratio
13.24 0.36 2.39
P/FCF Ratio
-2.01 -0.36 -2.02
P/OCF Ratio
-2.01 -0.37 -2.05
OCF/S Ratio
-11.04 -8.27 -4.24
Debt / Equity Ratio
3.73 0.50 0.76
Quick Ratio
3.95 6.87 4.33
Current Ratio
3.95 6.87 4.33
Asset Turnover
0.06 0.06 0.13
Interest Coverage
-25.16 -32.87 -25.45
Return on Equity
-9.88 -0.39 -1.06
Return on Assets
-0.98 -0.2 -0.49
Return on Invested Capital
-0.92 -0.32 -0.67
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
Gross Profit Margin
0.77 0.80 1.00
Net Profit Margin
-16.56 -3.31 -3.85
Pretax Profit Margin
-16.56 -6.36 -3.69
Operating Profit Margin
-12.98 -9.13 -4.23
FCF Margin
n/a n/a n/a
EBITDA Margin
-15.82 -5.88 -3.39